Corbus Pharmaceuticals
CRBP
40 hedge funds and large institutions have $79.4M invested in Corbus Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 11 increasing their positions, 3 reducing their positions, and 5 closing their positions.
320% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 5
267% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 3
212% more call options, than puts
Call options by funds: $862K | Put options by funds: $276K
160% more capital invested
Capital invested by funds: $30.6M → $79.4M (+$48.8M)
67% more funds holding
Funds holding: 24 → 40 (+16)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FI
Fosun International
Hong Kong,
China
|
+$2.9M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.22M |
| 3 |
CI
Conning Inc
Hartford,
Connecticut
|
+$1.46M |
| 4 |
IA
IFP Advisors
Tampa,
Florida
|
+$1.24M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$452K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$2.07M |
| 2 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$1.2M |
| 3 |
GTC
Ghost Tree Capital
New York
|
-$415K |
| 4 |
YP
Yellowstone Partners
Idaho Falls,
Idaho
|
-$115K |
| 5 |
Nomura Holdings
Tokyo,
Japan
|
-$36K |
CRBP Hedge Fund Activity: Q3 2016 in Review
40 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Corbus Pharmaceuticals (CRBP) for Q3 2016, worth a combined $79.4M — up 160% from $30.6M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new CRBP positions and 5 closed out — a net gain of 16 holders — while 11 added to existing stakes and 3 trimmed.
The largest buyer was Fosun International, opening a new position worth an estimated $2.9M. The largest seller was Perceptive Advisors, cutting an estimated $2.07M.
- 40 institutional investors held Corbus Pharmaceuticals (CRBP) as of Q3 2016, up from 24 in Q2 2016.
- Funds reported $79.4M of Corbus Pharmaceuticals stock for Q3 2016, up 160% quarter-over-quarter.
- 21 funds opened new Corbus Pharmaceuticals positions in Q3 2016 and 5 closed out, a net change of +16 holders.
- The largest Corbus Pharmaceuticals buyer in Q3 2016 was Fosun International, an estimated $2.9M added.
- The largest Corbus Pharmaceuticals seller in Q3 2016 was Perceptive Advisors, an estimated $2.07M sold.
Based on aggregated 13F filings for Q3 2016.